StockData

electroCore vs Vivani Medical

ECOR and VANI side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

ecorelectroCore$5.25−13.4% in 1 yearvaniVivani Medical$1.01−34.0% in 1 year

How ECOR and VANI compare

Vivani Medical is the larger company, worth 1.9 times as much as electroCore ($91.1M against $47.3M).

electroCore scores higher on the StockData Score (7 against 5 for Vivani Medical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricECORVANI
Size and price
Market cap$47.3M$91.1M
Share price$5.25$1.01
Change, 1 year−13.4%−34.0%
Change, 5 years−53.8%−85.6%
Beta (5Y)1.091.12
Employees8336
StockData Score
Total score7 (better)5
Valuation score1 (better)0
Growth score4 (better)0
Performance score1 (better)0
Health score15 (better)
Dividend score00
Valuation
P/S1.2×–
P/B–6.9×
FCF yield−23.0% (better)−28.2%
Growth
Revenue growth (TTM)27.3%–
Revenue growth, 5Y average55.7%–
Profitability
Gross margin87.7%–
Operating margin−33.1%–
Net margin−33.5%–
FCF margin−28.7%–
Return on equity–−372%
Financial health
Debt / equity–0.00
Interest coverage−960.7×–
Current ratio1.342.40 (better)
Altman Z-score−14.80−6.53 (better)
Piotroski F-score3 (better)2
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions11.4%5.8%
Held by insiders16.6%53.5%
Insider net buying, 12 months−$721K$16.7M (better)
Short interest, % of float4.8%0.88%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.